• OPEN AN ACCOUNT
Indian Indices
Sensex
76,835.78 776.01
( 1.02%)
Global Indices
Nasdaq
51,969.87 237.22
(0.46%)
Dow Jones
7,434.30 5.00
(0.07%)
Hang Seng
64,889.11 277.96
(0.43%)
Nikkei 225
10,802.25 66.02
(0.61%)
Forex
USD-INR
96.67 0.19
(0.20%)
EUR-INR
110.18 0.12
(0.10%)
GBP-INR
129.04 -0.01
(0.00%)
JPY-INR
0.59 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Zenotech Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532039
INE486F01012
15.5857255
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
270.3
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

radhagobind commercial ltd
Saregama India consolidated net profit rises 25.38% in the March 2026 quarter
May 14,2026
Net profit of Saregama India rose 25.38% to Rs 75.39 crore in the quarter ended March 2026 as against Rs 60.13 crore during the previous quarter ended March 2025. Sales rose 19.36% to Rs 287.44 crore in the quarter ended March 2026 as against Rs 240.82 crore during the previous quarter ended March 2025.

For the full year,net profit rose 1.38% to Rs 207.07 crore in the year ended March 2026 as against Rs 204.26 crore during the previous year ended March 2025. Sales declined 15.94% to Rs 984.62 crore in the year ended March 2026 as against Rs 1171.36 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales287.44240.82 19 984.621171.36 -16
OPM %42.0833.35 -34.2023.65 -
PBDT128.6293.26 38 374.16329.32 14
PBT104.9676.66 37 292.61271.11 8
NP75.3960.13 25 207.07204.26 1